Median telomeric content in samples with alterations in RAD21 was significantly higher than in WT for breast tumors, lung adenocarcinoma, and prostate acinar adenocarcinoma (Fig. 2C, Additional file 1: Table S4, p<0.0001 for all). This evidence concerns the gene RAD21 and prostatic acinar adenocarcinoma.